Crossmark

Step-down approach to concentration of intra-lesional triamcinolone acetonide in treatment of scalp patchy alopecia areata: insights from an open-label randomized trial

Crossref DOI link: https://doi.org/10.1007/s00403-025-04452-z

Published Online: 2025-11-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bansal, Bhavnish

Bansal, Shivani

Sushama, Sushama

Poonia, Kavita
License Information

Text and Data Mining valid from 2025-11-17

Version of Record valid from 2025-11-17
More Information

Article History

Received: 5 March 2025

Revised: 4 November 2025

Accepted: 5 November 2025

First Online: 17 November 2025

Declarations

:

: The authors declare no competing interests.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, as well as the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Institute IEC/AIIMS/BTI/260.

: The authors confirm that written informed consent has been obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below